- ￥600 - 1299
- Sino Biological
- 北京
- 13909-RP01
- 2025年08月12日
- ELISA
- Rabbit
- Human
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Recombinant Human Coagulation Factor VIII / FVIII / F8 protein
- 亚型：
Rabbit IgG
- 形态：
液体
- 保存条件：
-20℃ to -80℃
- 克隆性：
兔多抗
- 适应物种：
Human
- 保质期：
12个月
- 目录编号：
13909-RP01
- 级别：
免疫学试剂
- 库存：
99
- 供应商：
北京义翘神州科技股份有限公司
- 宿主：
Rabbit
- 应用范围：
ELISA
- 浓度：
ELISA: 1:1000-1:2000
- 靶点：
F8
- 抗体英文名：
Coagulation Factor VIII / FVIII / F8 Antibody, Rabbit PAb
- 抗体名：
Coagulation Factor VIII / FVIII / F8 Antibody, Rabbit PAb
- 规格：
20 µL/100 µL
| 规格： | 20 µL | 产品价格： | ￥600.0 |
|---|---|---|---|
| 规格： | 100 µL | 产品价格： | ￥1299.0 |
Coagulation Factor VIII / FVIII / F8 兔多抗（产品说明）
抗体种属：Human
抗体靶点：F8
抗体应用：ELISA
抗原描述：Recombinant Human Coagulation Factor VIII / FVIII / F8 protein
抗体宿主：Rabbit
抗体Ig类型：Rabbit IgG
抗体纯化方法：Protein A & Antigen Affinity
抗体制备：Produced in rabbits immunized with purified, recombinant Schistosoma japonicum Glutathione S-transferase / GST. Coagulation Factor VIII / FVIII / F8 specific IgG was purified by Human Coagulation Factor VIII / FVIII / F8 affinity chromatography.
抗体特异性：Human Coagulation Factor VIII / FVIII / F8
抗体保存：This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Defects of the factor VIII gene causes (f8 ) hemophilia A, an hemorrhagic X-linked disorder. The factor VIII gene is 186 kb long with 26 exons, varying from 69 bp (exon 5) to 3106 bp (exon 14) (1 ). The factor VIII mRNA is 9028 bases
Studies on Coagulation Incompatibilities for Xenotransplantation
) circulating PC in the presence of thrombin. Tissue factor pathway inhibitor (TFPI), is the primary inhibitor of tissue factor (TF)-induced coagulation. TFPI directly inhibits the activated factor X (FXa) and blocks the procoagulant activity of the TF/factor
Ex Vivo Stromal Cell Electroporation of Factor IX cDNA for Treatment of Hemophilia B
Hemophilia B is an X-linked genetic disorder that typically results from chronic circulating deficiency of blood coagulation factor IX (FIX) (1). While the occurrence of hemophilia B is significantly less frequent than hemophilia A (factor
技术资料暂无技术资料 索取技术资料
